OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins

Recent biochemical and genetic studies indicate that in addition to the octamer-binding proteins Oct-1 and Oct-2, other B cell components are required for lymphoid-restricted, octamer site-mediated immunoglobulin gene promoter activity. Using a genetic screen in yeast, we have isolated B cell-derived cDNAs encoding Oct-binding factor 1 (OBF-1), a novel protein that specifically associates with Oct-1 and Oct-2. Biochemical studies demonstrate that OBF-1 has no intrinsic DNA-binding activity and recognizes the POU domains of Oct-1 and Oct-2, but not those of Oct-4 and Oct-6. The OBF-1 mRNA is expressed in a highly cell-specific manner, being most abundant in B cells and essentially absent in most of the other cells or tissues tested. Furthermore, expression of OBF-1 in HeLa cells selectively stimulates the activity of a natural immunoglobulin promoter in an octamer site-dependent manner. Thus, OBF-1 has all the properties expected for a B cell-specific transcriptional coactivator protein.

[1]  M. Rosenfeld,et al.  POU-domain proteins Pit-1 and Oct-1 interact to form a heteromeric complex and can cooperate to induce expression of the prolactin promoter. , 1991, Genes & development.

[2]  H. Zachau,et al.  Correct transcription of an immunoglobulin κ gene requires an upstream fragment containing conserved sequence elements , 1984, Nature.

[3]  A. Heguy,et al.  Identification and purification of a human lymphoid-specific octamer-binding protein (OTF-2) that activates transcription of an immunoglobulin promoter in vitro , 1987, Cell.

[4]  M. Neuberger,et al.  Transcription cell type specificity is conferred by an immunoglobulin VH gene promoter that includes a functional consensus sequence , 1985, Cell.

[5]  L. Staudt,et al.  Immunoglobulin gene transcription. , 1991, Annual review of immunology.

[6]  Y. Nakamura,et al.  The human CCG1 gene, essential for progression of the G1 phase, encodes a 210-kilodalton nuclear DNA-binding protein , 1991, Molecular and cellular biology.

[7]  P. Sharp,et al.  A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes , 1986, Nature.

[8]  P. Sharp,et al.  Octamer-binding proteins from B or HeLa cells stimulate transcription of the immunoglobulin heavy-chain promoter in vitro. , 1988, Genes & development.

[9]  H. Schöler,et al.  Octamania: the POU factors in murine development. , 1991, Trends in genetics : TIG.

[10]  B. Trapp,et al.  Expression and activity of the POU transcription factor SCIP. , 1990, Science.

[11]  C. R. Goding,et al.  Herpes simplex virus regulatory elements and the immunoglobulin octamer domain bind a common factor and are both targets for virion transactivation , 1988, Cell.

[12]  R. Tjian,et al.  Coactivators and TAFs: a new class of eukaryotic transcription factors that connect activators to the basal machinery. , 1993, Cold Spring Harbor symposia on quantitative biology.

[13]  W. Schaffner,et al.  A cloned octamer transcription factor stimulates transcription from lymphoid–specific promoters in non–B cells , 1988, Nature.

[14]  E. Serfling,et al.  Octamer factors exert a dual effect on the IL-2 and IL-4 promoters. , 1994, Journal of immunology.

[15]  T. Jenuwein,et al.  Complex pattern of immunoglobulin mu gene expression in normal and transgenic mice: nonoverlapping regulatory sequences govern distinct tissue specificities. , 1991, Genes & development.

[16]  N. Heintz,et al.  Cell-cycle regulation of a human histone H2b gene is mediated by the H2b subtype-specific consensus element. , 1988, Genes & development.

[17]  E. A. O'neill,et al.  The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain , 1989, Cell.

[18]  M. Dreyfus,et al.  The conserved decanucleotide from the immunoglobulin heavy chain promoter induces a very high transcriptional activity in B‐cells when introduced into an heterologous promoter. , 1987, The EMBO journal.

[19]  Y. Kassir,et al.  A simple and highly efficient procedure for rescuing autonomous plasmids from yeast. , 1992, Nucleic acids research.

[20]  K. Okamoto,et al.  A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells , 1990, Cell.

[21]  T. Jacks,et al.  Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. , 1993, Genes & development.

[22]  R. Roeder,et al.  A herpesvirus trans-activating protein interacts with transcription factor OTF-1 and other cellular proteins. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Sharp,et al.  Recognition of the surface of a homeo domain protein. , 1992, Genes & development.

[24]  T. Wirth,et al.  Multiple Oct2 isoforms are generated by alternative splicing , 1991, Nucleic Acids Res..

[25]  P. Sharp,et al.  The octamer‐binding proteins form multi‐protein‐‐DNA complexes with the HSV alpha TIF regulatory protein. , 1989, The EMBO journal.

[26]  P. Matthias,et al.  Extinction of an immunoglobulin κ promoter in cell hybrids is mediated by the octamer motif and correlates with suppression of Oct-2 expression , 1990, Cell.

[27]  H. Schöler,et al.  Oct‐6: a POU transcription factor expressed in embryonal stem cells and in the developing brain. , 1990, The EMBO journal.

[28]  L. Staudt,et al.  An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity , 1987, Nature.

[29]  W. Herr,et al.  The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. , 1988, Genes & development.

[30]  P. Sharp,et al.  The B-cell-specific Oct-2 protein contains POU box- and homeo box-type domains. , 1988, Genes & development.

[31]  H. Singh,et al.  Targeted disruption of the Oct‐2 locus in a B cell provides genetic evidence for two distinct cell type‐specific pathways of octamer element‐mediated gene activation. , 1993, The EMBO journal.

[32]  H. Schöler,et al.  A nexus between Oct-4 and E1 A: Implications for gene regulation in embryonic stem cells , 1991, Cell.

[33]  R. Roeder,et al.  A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors , 1992, Cell.

[34]  G. Crabtree,et al.  Activation of early gene expression in T lymphocytes by Oct-1 and an inducible protein, OAP40. , 1991, Science.

[35]  R. Tjian,et al.  Cloning and expression of human TAFII250: a TBP-associated factor implicated in cell-cycle regulation , 1993, Nature.

[36]  J. Mizushima-Sugano,et al.  Cell-type-specific transcription of an immunoglobulin kappa light chain gene in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[37]  W. Herr,et al.  A single amino acid exchange transfers VP16-induced positive control from the Oct-1 to the Oct-2 homeo domain. , 1992, Genes & development.

[38]  K. Struhl,et al.  Functional differences between yeast and human TFIID are localized to the highly conserved region , 1991, Cell.

[39]  S. Rusconi,et al.  Eukaryotic expression vectors for the analysis of mutant proteins. , 1989, Nucleic Acids Research.

[40]  T. Wirth,et al.  Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity , 1992, Molecular and cellular biology.

[41]  W. Schaffner,et al.  Cell type‐specificity elements of the immunoglobulin heavy chain gene enhancer. , 1987, The EMBO journal.

[42]  S. Fields,et al.  A novel genetic system to detect protein–protein interactions , 1989, Nature.

[43]  K. Struhl,et al.  A wide variety of DNA sequences can functionally replace a yeast TATA element for transcriptional activation. , 1990, Genes & development.

[44]  T. Wirth,et al.  Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell‐specific activities. , 1994, The EMBO journal.

[45]  J. D. Capra,et al.  The ubiquitous octamer-binding protein(s) is sufficient for transcription of immunoglobulin genes , 1990, Molecular and cellular biology.

[46]  M. Horikoshi,et al.  The p250 subunit of native TATA box-binding factor TFIID is the cell-cycle regulatory protein CCG1 , 1993, Nature.

[47]  R. Roeder,et al.  Proline-rich activator CTF1 targets the TFIIB assembly step during transcriptional activation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[48]  W. Schaffner,et al.  Transcription factor Oct‐2A contains functionally redundant activating domains and works selectively from a promoter but not from a remote enhancer position in non‐lymphoid (HeLa) cells. , 1990, The EMBO journal.

[49]  A. Pierani,et al.  Purified octamer binding transcription factors stimulate RNA polymerase III-mediated transcription of the 7SK RNA gene , 1989, Cell.

[50]  K. Struhl,et al.  Saturation mutagenesis of a yeast his3 "TATA element": genetic evidence for a specific TATA-binding protein. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[51]  K. Struhl,et al.  Current Protocols in Molecular Biology (New York: Greene Publishing Associates and Wiley-Interscience). Host-Range Shuttle System for Gene Insertion into the Chromosomes of Gram-negative Bacteria. , 1988 .

[52]  H. Schöler,et al.  Oct‐4: a germline‐specific transcription factor mapping to the mouse t‐complex. , 1990, The EMBO journal.

[53]  G. Ruvkun,et al.  The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. , 1988, Genes & development.

[54]  R. Tjian,et al.  Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. , 1988, Genes & development.

[55]  A. Heguy,et al.  Activation of octamer-containing promoters by either octamer-binding transcription factor 1 (OTF-1) or OTF-2 and requirement of an additional B-cell-specific component for optimal transcription of immunoglobulin promoters , 1990, Molecular and cellular biology.